InvestorsHub Logo
Followers 0
Posts 8
Boards Moderated 0
Alias Born 11/09/2017

Re: None

Friday, 11/10/2017 9:56:26 AM

Friday, November 10, 2017 9:56:26 AM

Post# of 6305
How pathetic management of NVIV has been...the CEO and BOD, of which the CEO is Chairman, have truly ignored shareholders. CEO Perrin has already led one company to Bankruptcy (ConjuChem) and hired Director Merrifield, who too led a company to bankruptcy (PathoGenetix).
Perrin gets $8000 a day. You'd think he'd be inspired to work for it, but the BOD's appear to forget INSPIRE is stagnant. Perrin himself halted it. The trial with it's current patient population has already exceeded the 25% success rate: it's initial goal. The device should already be on the market.
The fish head is gone. We have reached the fins.